Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 561.14%3.06M | 22.84%-20.36M | -124.68%-664K | -211.23%-26.39M | -74.09%2.69M | -170.48%-8.48M | -34.32%10.38M | 2.85%12.03M | 395.00%15.81M | 11.82%11.7M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 77.63%-49K | -209.73%-700K | -68.46%-219K | -28.41%-226K | -319.35%-130K | 85.28%-176K | 97.76%-31K | 22.94%-1.2M | -46.35%-1.38M | 29.29%-1.55M |
| Interest expense - adjustment | -12.12%457K | 68.61%1.76M | 113.99%520K | 0.77%1.05M | -58.18%243K | -36.03%1.04M | -30.83%581K | 25.56%1.62M | 55.27%840K | -10.78%1.29M |
| Investment loss (gain) | ---- | 377.84%953K | ---- | 60.67%-343K | ---- | -22.99%-872K | ---- | -212.72%-709K | ---- | --629K |
| Attributable subsidiary (profit) loss | 264.29%408K | ---- | 119.18%112K | ---- | -5.61%-584K | ---- | -111.07%-553K | ---- | -127.83%-262K | ---- |
| Impairment and provisions: | ---- | 33.51%9.05M | ---- | 184.55%6.78M | ---- | 244.45%2.38M | ---- | -117.77%-1.65M | ---- | 144.95%9.28M |
| -Other impairments and provisions | ---- | 33.51%9.05M | ---- | 184.55%6.78M | ---- | 244.45%2.38M | ---- | -117.77%-1.65M | ---- | 144.95%9.28M |
| Revaluation surplus: | ---- | -231.03%-5.46M | ---- | -200.00%-1.65M | ---- | -51.47%1.65M | ---- | 164.54%3.4M | ---- | -2,267.90%-5.27M |
| -Other fair value changes | ---- | -231.03%-5.46M | ---- | -200.00%-1.65M | ---- | -51.47%1.65M | ---- | 164.54%3.4M | ---- | -2,267.90%-5.27M |
| Depreciation and amortization: | -27.93%2.43M | 2.52%6.92M | -22.47%3.37M | -13.20%6.75M | 10.91%4.34M | -16.56%7.77M | -19.68%3.91M | -5.94%9.32M | -4.40%4.87M | -0.45%9.9M |
| -Amortization of intangible assets | 2.50%164K | -7.79%994K | -7.51%160K | -8.02%1.08M | -70.83%173K | -35.32%1.17M | -49.53%593K | 161.10%1.81M | 6,811.76%1.18M | 1,019.35%694K |
| Special items | -77.23%609K | 157.13%5.35M | --2.68M | ---9.37M | ---- | ---- | ---- | 8,166.67%248K | ---- | 100.41%3K |
| Adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---18K |
| Operating profit before the change of operating capital | 19.40%6.91M | 89.35%-2.49M | -11.74%5.79M | -806.03%-23.41M | -54.11%6.56M | -85.63%3.32M | -28.08%14.29M | -11.19%23.06M | 2,644.56%19.87M | 13.77%25.97M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 7.70%-4.81M | -75.91%-3.62M | -342.71%-5.21M | -141.66%-2.06M | 131.14%2.15M | 115.93%4.93M | -136.62%-6.9M | 43.31%-30.97M | 31.61%-2.91M | -65.73%-54.63M |
| Accounts receivable (increase)decrease | -146.43%-65.59M | 125.27%11.3M | -173.51%-26.62M | -91.50%5.02M | 186.59%36.21M | 3,901.69%59.07M | 145.23%12.63M | 104.21%1.48M | -146.46%-27.93M | -238.27%-35.02M |
| Accounts payable increase (decrease) | 71.20%59.03M | 225.94%21.4M | 346.99%34.48M | 75.38%-16.99M | 33.33%-13.96M | -672.51%-69.01M | -151.98%-20.94M | -81.30%12.05M | 355.00%40.28M | 210.48%64.45M |
| prepayments (increase)decrease | ---- | -63.88%10.91M | ---- | 383.07%30.21M | ---- | 58.18%-10.67M | ---- | -137.74%-25.52M | ---- | 188.59%67.62M |
| Special items for working capital changes | ---- | ---- | ---90K | ---- | ---- | ---- | ---- | ---- | ---- | --18K |
| Adjustment items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | --13.79M | ---- | ---- | ---- |
| Cash from business operations | -153.47%-4.46M | 619.17%37.51M | -73.03%8.35M | 41.56%-7.23M | 140.24%30.96M | 37.86%-12.36M | -56.03%12.89M | -129.09%-19.9M | -25.41%29.3M | 144.09%68.41M |
| Other taxs | -138.89%-559K | -133.30%-355K | -119.75%-234K | 125.63%1.07M | 138.25%1.19M | -22.61%-4.16M | -16.95%-3.1M | 55.47%-3.39M | ---2.65M | -172.76%-7.62M |
| Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---18K |
| Adjustment items of business operations | ---- | ---- | --90K | ---- | ---- | ---- | ---- | ---- | ---- | --18K |
| Net cash from operations | -161.22%-5.02M | 703.26%37.16M | -74.47%8.21M | 62.73%-6.16M | 228.39%32.14M | 29.05%-16.52M | -63.28%9.79M | -138.31%-23.29M | -32.15%26.66M | 142.02%60.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -62.02%49K | 209.73%700K | -0.77%129K | 28.41%226K | 319.35%130K | -85.28%176K | 1,450.00%31K | -22.94%1.2M | -99.79%2K | 26.69%1.55M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.39M | --1.41M | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3K |
| Purchase of fixed assets | ---- | 97.69%-110K | ---- | -556.41%-4.76M | -302.97%-2.31M | -22.47%-725K | -266.67%-572K | 57.92%-592K | 75.78%-156K | -27.45%-1.41M |
| Purchase of intangible assets | ---- | ---- | ---- | ---15K | ---- | ---- | ---- | 96.11%-303K | 30.26%-710K | -1,710.23%-7.78M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 118.03%274K |
| Net cash from investment operations | -62.02%49K | 112.97%590K | 105.93%129K | -728.42%-4.55M | -302.03%-2.18M | -132.50%-549K | -199.63%-541K | 122.94%1.69M | 1,292.31%543K | -262.59%-7.36M |
| Net cash before financing | -159.68%-4.97M | 452.53%37.75M | -72.19%8.33M | 37.29%-10.71M | 224.09%29.97M | 20.97%-17.07M | -66.00%9.25M | -140.43%-21.6M | -30.84%27.2M | 138.12%53.43M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -33.69%10.23M | ---- | 5.95%15.43M | ---- | 4.68%14.56M | ---- | -80.12%13.91M | -47.47%18M | 48.05%69.97M |
| Refund | 7.19%-2.69M | 15.69%-14.59M | 69.53%-2.89M | 17.48%-17.3M | -28.96%-9.5M | -7.64%-20.97M | 18.88%-7.37M | 47.77%-19.48M | 37.04%-9.08M | 15.17%-37.29M |
| Interest paid - financing | -10.87%-306K | -88.43%-1.42M | -22.12%-276K | -9.62%-752K | 48.98%-226K | 39.56%-686K | -41.53%-443K | -78.18%-1.14M | 42.14%-313K | -27.40%-637K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 0.00%-5M | -106.02%-5M | 0.00%-5M | ---2.43M | 49.48%-5M |
| Net cash from financing operations | 7.92%-4.72M | -39.01%-9.56M | 59.25%-5.13M | 63.12%-6.88M | 21.17%-12.58M | 0.48%-18.65M | -674.86%-15.96M | -193.65%-18.74M | -82.55%2.78M | 236.92%20.01M |
| Effect of rate | -103.88%-142K | 50.42%-472K | 166.11%3.66M | 83.29%-952K | 71.97%-5.54M | -24.04%-5.7M | -2,797.36%-19.76M | -92.66%-4.59M | -169.03%-682K | -390.38%-2.38M |
| Net Cash | -402.18%-9.69M | 260.29%28.19M | -81.55%3.21M | 50.77%-17.58M | 359.01%17.39M | 11.45%-35.72M | -122.39%-6.71M | -154.93%-40.34M | -45.73%29.97M | 147.45%73.44M |
| Begining period cash | 56.85%76.46M | -27.55%48.74M | -27.55%48.74M | -38.10%67.28M | -38.10%67.28M | -29.25%108.7M | -29.25%108.7M | 86.05%153.63M | 86.05%153.63M | -65.09%82.58M |
| Cash at the end | 19.79%66.62M | 56.85%76.46M | -29.72%55.61M | -27.55%48.74M | -3.77%79.13M | -38.10%67.28M | -55.05%82.23M | -29.25%108.7M | 31.80%182.92M | 86.05%153.63M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.